Latest news articles

Added 2 years ago Drug news

FDA approves DigniCap Cooling System for use in cancer patients with solid tumors- Dignitana

The FDA has cleared the expanded use of a cooling cap, DigniCap Cooling System, from Dignitana , to reduce hair...

Added 4 years ago Drug news

FDA approves DigniCap scalp cooling system to reduce chemotherapy induced hair loss- Dignitana

Dignitana, a world leader in medical scalp-cooling technology, announced that the FDA has granted the company’s de novo application to...

Added 5 years ago Drug news

Sandoz files Zarzio biosimilar for Neutropenia at FDA.

Sandoz announced that the FDA has accepted its Biologics License Application for filgrastim, which was filed under the new biosimilar...

Search all news articles for Maintenance chemotherapy or radiotherapy

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Chronic Lymphocytic Leukaemia (CLL)

Chronic Lymphocytic Leukaemia (CLL)

Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more

+ 1 more

Metastatic Melanoma

Metastatic Melanoma

Do you know your ABCDE of melanoma identification? Learn the characteristic signs of malignant skin lesions here.

Load more

Journal articles

Clinical presentation and risk factors of serious infections in children with Down syndrome treated for acute lymphoblastic leukemia.

Treatment of acute lymphoblastic leukemia (ALL) in children with Down syndrome (DS) is associated with a higher incidence of life-threatening infections compared to the overall pediatric population. 

Added 3 years ago

Lifetime effectiveness of mifamurtide addition to chemotherapy in nonmetastatic and metastatic osteosarcoma: a Markov process model analysis.

The mortality and progression rates in osteosarcoma differ depending on the presence of metastasis. A decision model would be useful...

Added 4 years ago

Clofarabine-based combination chemotherapy for relapse and refractory childhood acute lymphoblastic leukemia.

Clofarabine, one of the key treatment agents for refractory and relapsed acute lymphoblastic leukemia (ALL), achieves a remission rate of...

Added 5 years ago

Search all journal articles for Maintenance chemotherapy or radiotherapy